New drug pricing system leaves drugmakers in jitters

Korean drug companies are said to face jitters as the National Health Insurance Corporation (NHIC) is reconsidering introducing the “reference price system (RPS),” which was already scrapped in 2002 due to vigorous oppositions from lawmakers, medical and pharmaceutical camps and civic groups.

In its recent report, the NHIC claimed that Korea needs to introduce the new drug pricing system by ...